The Walla Walla VA Medical Center seeks to purchase a Molecular PCR Analyzer for detecting pathogens related to Women’s Health and Sexual Health. The analyzer must perform qualitative PCR tests on FDA-approved, self-collected samples, including endocervical, vaginal, pharyngeal, rectal, and urine specimens. Testing must be multiplexed efficiently to include all analytes in the fewest test panels. No specific timelines, budget amounts, or performance location are mentioned in the description. This opportunity is relevant for bidders offering advanced PCR diagnostic solutions for clinical self-collection applications.

The Department of Veterans Affairs is seeking contractors to provide reagents and consumables for molecular PCR testing, specifically for women’s health and sexual health pathogens, at the Jonathan M. Wainwright Memorial VA Medical Center and its associated clinics in Washington and Oregon. The required analyzer must deliver rapid test results within 1.0 to 1.5 hours for same-day diagnosis, support multiplex vaginal panels and CT/NG testing on a single platform, and accommodate self-collected samples. The platform should also be compatible with future decentralized testing for additional assays like COVID-19, Influenza, and MRSA. Interested parties must submit a capabilities statement to Hector Gonzalez by July 21st, 2026, at 10:00 AM PST. No budget amount or specific performance location beyond the listed VA facilities is provided.